US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Therapeutics

29.00

0.0000

Volume:34.37K

Turnover:1.00M

Market Cap:816.24M

PE:-16.39

High:29.93

Open:29.59

Low:28.60

Close:29.00

Loading ...

Overview Company News Filings

Candel Therapeutics to hold a conference call

Kymera Therapeutics Is Maintained at Overweight by JP Morgan

Cognition Therapeutics Launches Expanded Access Program for Zervimesine

Vera Therapeutics Secures $500M Loan Agreement

JW Therapeutics Approves License Agreement at EGM

Press Release: Vera Therapeutics Announces Refinancing of Existing Oxford Debt Facility, Providing up to $500 Million of Term Loans

Solvonis Therapeutics Appoints Renowned Neuroscientist as Chief Scientific Officer

ProQR Therapeutics Reports Q1 2025 Financial Results

Kymera Therapeutics upgraded to Overweight from Equal Weight at Morgan Stanley

Repare Therapeutics Strengthens Leadership with New Executive Appointment

Outlook Therapeutics Launches LYTENAVA in Europe

Eterna Therapeutics Increases Authorized Shares and Amends Bylaws

CERo Therapeutics Expands Leadership with New Executive Roles

Rapport Therapeutics Completes Enrollment for Phase 2a Trial

Autolus Therapeutics Releases UK Annual Report 2024

Small U.S. Stocks End Mixed As Vera Therapeutics Lead, Diginex Lags

Protara Therapeutics Names William Conkling as Chief Commercial Officer

MT Newswires Live

Trevi Therapeutics price target raised to $23 from $20 at Oppenheimer

Press Release: Protara Therapeutics Announces Appointment of William Conkling as Chief Commercial Officer

Buy Rating for Trevi Therapeutics Driven by Promising Haduvio Trial Results and Market Opportunities

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/LENZ/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LENZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LENZ\",,,,,undefined,":{"symbol":"LENZ","market":"US","secType":"STK","nameCN":"Therapeutics","latestPrice":29,"timestamp":1750086564922,"preClose":29,"halted":0,"volume":34367,"delay":0,"floatShares":11653723,"shares":28146154,"eps":-1.769251,"marketStatus":"Trading","change":0,"latestTime":"06-16 11:09:52 EDT","open":29.59,"high":29.925,"low":28.595,"amount":1000860.483873,"amplitude":0.045862,"askPrice":29.19,"askSize":9,"bidPrice":28.81,"bidSize":10,"shortable":3,"etf":0,"ttmEps":-1.769251,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1750104000000},"marketStatusCode":2,"adr":0,"listingDate":1624593600000,"exchange":"NASDAQ","adjPreClose":29,"preHourTrading":{"tag":"盘前","latestPrice":29.05,"preClose":29,"latestTime":"09:25 EDT","volume":24,"amount":697.2,"timestamp":1750080300014},"postHourTrading":{"tag":"盘后","latestPrice":29,"preClose":29,"latestTime":"19:54 EDT","volume":608,"amount":17570.81,"timestamp":1749858862399},"volumeRatio":0.291858,"impliedVol":0.5638,"impliedVolPercentile":0.5957},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LENZ\",,,,,undefined,":{"symbol":"LENZ","floatShares":11653723,"roa":"-17.75%","roe":"-24.47%","lyrEps":-2.338654,"volumeRatio":0.291858,"shares":28146154,"dividePrice":0,"high":29.925,"amplitude":0.045862,"preClose":29,"low":28.595,"week52Low":16.28,"pbRate":"4.25","week52High":38.93,"institutionHeld":0,"latestPrice":29,"committee":0.052632,"eps":-1.769251,"divideRate":0,"volume":34367,"delay":0,"ttmEps":-1.769251,"open":29.59,"prevYearClose":28.87,"prevWeekClose":29,"prevMonthClose":29.2,"prevQuarterClose":25.71,"fiveDayClose":31.22,"twentyDayClose":26.81,"sixtyDayClose":26.3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LENZ\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2540708300","title":"Candel Therapeutics to hold a conference call","url":"https://stock-news.laohu8.com/highlight/detail?id=2540708300","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540708300?lang=en_us&edition=fundamental","pubTime":"2025-06-03 22:35","pubTimestamp":1748961311,"startTime":"0","endTime":"0","summary":"Management discusses expert clinical perspectives on CAN-2409 Phase 3 prostate cancer data on a conference call to be held on June 3 at 1 pm. Webca...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/candel-therapeutics-to-hold-a-conference-call-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/candel-therapeutics-to-hold-a-conference-call-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4539","BK4526","BK4600","BK4139","BK4170","BK4595","BK4007","CADL"],"gpt_icon":0},{"id":"2540771333","title":"Kymera Therapeutics Is Maintained at Overweight by JP Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2540771333","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540771333?lang=en_us&edition=fundamental","pubTime":"2025-06-03 20:21","pubTimestamp":1748953260,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KYMR/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 03, 2025 08:21 ET (12:21 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYMR","LENZ"],"gpt_icon":0},{"id":"2540572779","title":"Cognition Therapeutics Launches Expanded Access Program for Zervimesine","url":"https://stock-news.laohu8.com/highlight/detail?id=2540572779","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540572779?lang=en_us&edition=fundamental","pubTime":"2025-06-03 19:57","pubTimestamp":1748951873,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics ( ($CGTX) ) just unveiled an announcement. On June 3, 2025, Cognition Therapeutics announced the launch of an expanded acces...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cognition-therapeutics-launches-expanded-access-program-for-zervimesine?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cognition-therapeutics-launches-expanded-access-program-for-zervimesine?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LENZ","BK4539","BK4007","CGTX"],"gpt_icon":0},{"id":"2540775634","title":"Vera Therapeutics Secures $500M Loan Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2540775634","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540775634?lang=en_us&edition=fundamental","pubTime":"2025-06-03 18:57","pubTimestamp":1748948278,"startTime":"0","endTime":"0","summary":"Vera Therapeutics ( ($VERA) ) has shared an announcement. On June 2, 2025, Vera Therapeutics entered into a Loan and Security Agreement with Oxford...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vera-therapeutics-secures-500m-loan-agreement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vera-therapeutics-secures-500m-loan-agreement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","VERA","BK4588","BK4585","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2540977318","title":"JW Therapeutics Approves License Agreement at EGM","url":"https://stock-news.laohu8.com/highlight/detail?id=2540977318","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540977318?lang=en_us&edition=fundamental","pubTime":"2025-06-03 18:38","pubTimestamp":1748947096,"startTime":"0","endTime":"0","summary":"The latest update is out from JW (Cayman) Therapeutics Co. Ltd. ( ($HK:2126) ). JW (Cayman) Therapeutics Co. Ltd held an Extraordinary General Meet...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/jw-therapeutics-approves-license-agreement-at-egm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/jw-therapeutics-approves-license-agreement-at-egm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4007","BK4539","LENZ"],"gpt_icon":0},{"id":"2540780497","title":"Press Release: Vera Therapeutics Announces Refinancing of Existing Oxford Debt Facility, Providing up to $500 Million of Term Loans","url":"https://stock-news.laohu8.com/highlight/detail?id=2540780497","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540780497?lang=en_us&edition=fundamental","pubTime":"2025-06-03 18:30","pubTimestamp":1748946600,"startTime":"0","endTime":"0","summary":"BRISBANE, Calif., June 03, 2025  -- Vera Therapeutics, Inc. , a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced that it has entered into a new credit facility providing for up to $500 million of term loans with its current partner Oxford Finance LLC . The new credit facility will replace Vera's existing $50 million credit facility. The initial funding of the new credit facility will be in a principal amount of $75 million and is expected to occur on June 4, 2025.-- Lowered Interest Rate: Reduced borrowing cost by 320 basis points based. on current interest rates. The facility will mature five years from the. 2026, not subject to additional performance milestones. Vera has the. million at the mutual discretion of Vera and Oxford.this refinancing, Vera will no longer be required to make principal. in a cost-effective refinancing that significantly lowers Vera's ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4202","OXM","BK4213","BKV","BK4007","BK4539","VERA","LENZ","BK4139"],"gpt_icon":0},{"id":"2540742565","title":"Solvonis Therapeutics Appoints Renowned Neuroscientist as Chief Scientific Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2540742565","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540742565?lang=en_us&edition=fundamental","pubTime":"2025-06-03 14:16","pubTimestamp":1748931378,"startTime":"0","endTime":"0","summary":"Graft Polymer (UK) PLC ( ($GB:SVNS) ) has issued an announcement. Solvonis Therapeutics plc has appointed Professor David Nutt as Chief Scientific ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/solvonis-therapeutics-appoints-renowned-neuroscientist-as-chief-scientific-officer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/solvonis-therapeutics-appoints-renowned-neuroscientist-as-chief-scientific-officer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4205","BK4007","BK4539","BK4139","BK4233","UK","BK4528","LENZ"],"gpt_icon":0},{"id":"2540746662","title":"ProQR Therapeutics Reports Q1 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2540746662","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540746662?lang=en_us&edition=fundamental","pubTime":"2025-06-03 11:51","pubTimestamp":1748922706,"startTime":"0","endTime":"0","summary":"ProQR Therapeutics BV ( ($PRQR) ) has released its Q1 earnings. Here is a breakdown of the information ProQR Therapeutics BV presented to its inves...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/proqr-therapeutics-reports-q1-2025-financial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/proqr-therapeutics-reports-q1-2025-financial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LENZ","BK4007","BK4539"],"gpt_icon":0},{"id":"2540719116","title":"Kymera Therapeutics upgraded to Overweight from Equal Weight at Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2540719116","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540719116?lang=en_us&edition=fundamental","pubTime":"2025-06-03 07:15","pubTimestamp":1748906106,"startTime":"0","endTime":"0","summary":"Morgan Stanley upgraded Kymera Therapeutics (KYMR) to Overweight from Equal Weight with a price target of $79, up from $49. The company reported Ph...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kymera-therapeutics-upgraded-to-overweight-from-equal-weight-at-morgan-stanley-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kymera-therapeutics-upgraded-to-overweight-from-equal-weight-at-morgan-stanley-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","KYMR"],"gpt_icon":0},{"id":"2540981716","title":"Repare Therapeutics Strengthens Leadership with New Executive Appointment","url":"https://stock-news.laohu8.com/highlight/detail?id=2540981716","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540981716?lang=en_us&edition=fundamental","pubTime":"2025-06-03 05:42","pubTimestamp":1748900537,"startTime":"0","endTime":"0","summary":"Repare Therapeutics ( ($RPTX) ) just unveiled an update. Repare Therapeutics Inc. has announced an amendment to its previous report, detailing the ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/repare-therapeutics-strengthens-leadership-with-new-executive-appointment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/repare-therapeutics-strengthens-leadership-with-new-executive-appointment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4539","BK4139","RPTX","LENZ"],"gpt_icon":0},{"id":"2540716336","title":"Outlook Therapeutics Launches LYTENAVA in Europe","url":"https://stock-news.laohu8.com/highlight/detail?id=2540716336","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540716336?lang=en_us&edition=fundamental","pubTime":"2025-06-03 05:27","pubTimestamp":1748899679,"startTime":"0","endTime":"0","summary":"Outlook Therapeutics ( ($OTLK) ) has provided an update. On June 2, 2025, Outlook Therapeutics announced the commercial launch of LYTENAVA™ (bevaci...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/outlook-therapeutics-launches-lytenava-in-europe?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/outlook-therapeutics-launches-lytenava-in-europe?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4539","BK4007","BK4139"],"gpt_icon":0},{"id":"2540971524","title":"Eterna Therapeutics Increases Authorized Shares and Amends Bylaws","url":"https://stock-news.laohu8.com/highlight/detail?id=2540971524","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540971524?lang=en_us&edition=fundamental","pubTime":"2025-06-03 05:05","pubTimestamp":1748898315,"startTime":"0","endTime":"0","summary":"Eterna Therapeutics ( ($ERNA) ) has shared an announcement. On June 2, 2025, Ernexa Therapeutics Inc. made significant amendments to its Restated C...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/eterna-therapeutics-increases-authorized-shares-and-amends-bylaws?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/eterna-therapeutics-increases-authorized-shares-and-amends-bylaws?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2540371563","title":"CERo Therapeutics Expands Leadership with New Executive Roles","url":"https://stock-news.laohu8.com/highlight/detail?id=2540371563","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540371563?lang=en_us&edition=fundamental","pubTime":"2025-06-03 04:48","pubTimestamp":1748897285,"startTime":"0","endTime":"0","summary":"The latest update is out from CERo Therapeutics Holdings ( ($CERO) ). CERo Therapeutics Holdings, Inc. has entered into new employment agreements w...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cero-therapeutics-expands-leadership-with-new-executive-roles?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cero-therapeutics-expands-leadership-with-new-executive-roles?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4539","BK4139","LENZ"],"gpt_icon":0},{"id":"2540130847","title":"Rapport Therapeutics Completes Enrollment for Phase 2a Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2540130847","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540130847?lang=en_us&edition=fundamental","pubTime":"2025-06-03 04:34","pubTimestamp":1748896471,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics, Inc. ( ($RAPP) ) has shared an announcement. On June 2, 2025, Rapport Therapeutics announced that its Phase 2a trial for RAP-...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/rapport-therapeutics-completes-enrollment-for-phase-2a-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/rapport-therapeutics-completes-enrollment-for-phase-2a-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RAPP","BK4007","BK4539","LENZ","BK4139"],"gpt_icon":0},{"id":"2540137967","title":"Autolus Therapeutics Releases UK Annual Report 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2540137967","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540137967?lang=en_us&edition=fundamental","pubTime":"2025-06-03 04:33","pubTimestamp":1748896426,"startTime":"0","endTime":"0","summary":"Autolus Therapeutics ( ($AUTL) ) has shared an announcement. On June 2, 2025, Autolus Therapeutics plc released its UK Annual Report and Accounts f...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/autolus-therapeutics-releases-uk-annual-report-2024?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/autolus-therapeutics-releases-uk-annual-report-2024?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","LENZ","BK4007","AUTL"],"gpt_icon":0},{"id":"2540713624","title":"Small U.S. Stocks End Mixed As Vera Therapeutics Lead, Diginex Lags","url":"https://stock-news.laohu8.com/highlight/detail?id=2540713624","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540713624?lang=en_us&edition=fundamental","pubTime":"2025-06-03 04:20","pubTimestamp":1748895600,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of small-cap companies were mixed Monday, as the Russell 2000 Index added 0.2%, while the S&P Small Cap 600 Index was down 0.4%.Among companies with a market value of $1 billion to $6.7 billion, Vera Therapeutics Inc. was the best performer during the session, surging 67%, followed by Applied Digital Corp., which jumped 48%. Kymera Therapeutics Inc. shares surged 46%, Blueprint Medicines Corp. surged 26%, and shares of Cleveland-Cliffs Inc. jumped 23%.Diginex Ltd. was the biggest laggard, dropping 15%, followed by shares of Science Applications International Corp., which dropped 13%. Shares of GIBO Holdings Ltd. Cl A dropped 11%, TMC the metals company Inc. shares plunged 11%, and Novocure Ltd. plunged 11%.Major stock indexes in the U.S. rose Monday as the Nasdaq Composite Index added 0.7%. Meanwhile, the S&P 500 Index added 0.4%, and the Dow Jones Industrial Average increased 0.1%.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VERA","BK4007","BK4139","BK4588","LENZ","BK4585","BK4539"],"gpt_icon":0},{"id":"2540571357","title":"Protara Therapeutics Names William Conkling as Chief Commercial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2540571357","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540571357?lang=en_us&edition=fundamental","pubTime":"2025-06-03 04:17","pubTimestamp":1748895436,"startTime":"0","endTime":"0","summary":"Protara Therapeutics (TARA) said Monday it appointed William Conkling as chief commercial officer.Conkling most recently served as president and CEO of Rafael Holdings (RFL).","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4233","BK4205","BK4007","BK4139","RFL","LENZ","BK4539","TARA"],"gpt_icon":0},{"id":"2540713617","title":"Trevi Therapeutics price target raised to $23 from $20 at Oppenheimer","url":"https://stock-news.laohu8.com/highlight/detail?id=2540713617","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540713617?lang=en_us&edition=fundamental","pubTime":"2025-06-03 04:15","pubTimestamp":1748895332,"startTime":"0","endTime":"0","summary":"Oppenheimer raised the firm’s price target on Trevi Therapeutics (TRVI) to $23 from $20 and keeps an Outperform rating on the shares. The company’s...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/trevi-therapeutics-price-target-raised-to-23-from-20-at-oppenheimer-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/trevi-therapeutics-price-target-raised-to-23-from-20-at-oppenheimer-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OPY","LENZ"],"gpt_icon":0},{"id":"2540371806","title":"Press Release: Protara Therapeutics Announces Appointment of William Conkling as Chief Commercial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2540371806","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540371806?lang=en_us&edition=fundamental","pubTime":"2025-06-03 04:04","pubTimestamp":1748894640,"startTime":"0","endTime":"0","summary":"NEW YORK, June 02, 2025  -- Protara Therapeutics, Inc. , a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the appointment of William \"Bill\" Conkling as Chief Commercial Officer. He brings more than two decades of experience developing and commercializing novel cancer and rare disease therapeutics to Protara.Mr. Conkling most recently served as President and Chief Executive Officer of Rafael Holdings, Inc., a holding company with interests in clinical and early-stage pharmaceutical companies. Prior to assuming his role as Chief Executive Officer, he served as the company's Chief Commercial and Business Officer where he was responsible for building the commercial organization and developing the go-to-market strategy for the company's assets.Protara is a clinical-stage biotechnology company committed to advancing transformative therapies for people with cancer and rare diseases. Protara's portfolio includes its lea","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TARA","BK4139","BK4135","BCG","LENZ","BK4007","BK4539"],"gpt_icon":0},{"id":"2540718623","title":"Buy Rating for Trevi Therapeutics Driven by Promising Haduvio Trial Results and Market Opportunities","url":"https://stock-news.laohu8.com/highlight/detail?id=2540718623","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540718623?lang=en_us&edition=fundamental","pubTime":"2025-06-03 03:25","pubTimestamp":1748892328,"startTime":"0","endTime":"0","summary":"JonesTrading analyst Debanjana Chatterjee has maintained their bullish stance on TRVI stock, giving a Buy rating today. Debanjana Chatterjee’s rati...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-for-trevi-therapeutics-driven-by-promising-haduvio-trial-results-and-market-opportunities?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-for-trevi-therapeutics-driven-by-promising-haduvio-trial-results-and-market-opportunities?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LENZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-05-08","symbol":"LENZ","fiscalQuarterEnding":"2024/03","expectedEps":-0.84,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"pre","actualEps":-3.53},{"market":"US","date":"2024-03-22","symbol":"LENZ","defaultRemindTime":1711114200000,"type":"split","dateTimestamp":1711080000000,"forFactor":7,"toFactor":1,"ratio":7},{"date":"2024-03-22","symbol":"LENZ","amount":1.03,"announcedDate":null,"type":"dividend","market":"US","newRecordDate":"2024-03-18","name":"Therapeutics","recordDate":"2024-03-21","payableDate":"2024-03-18","currency":"USD","dateTimestamp":1711080000000,"payDate":"2024-03-21"},{"market":"US","date":"2021-08-12","symbol":"LENZ","fiscalQuarterEnding":"2021/06","expectedEps":-1.11,"name":null,"time":"","type":"earning","dateTimestamp":1628740800000,"reportTimeType":"","actualEps":-3.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LENZ\",market:\"US\",,,undefined,":[{"executeDate":"2024-03-22","recordDate":"2024-03-18","paymentDate":"2024-03-21","value":1.03,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LENZ\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":8,"updateTime":1742270400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LENZ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LENZ","date":"2025-06-13","current":-17.439532,"percent":0.017422,"low":-18.842712,"twenty":-14.747436,"median":-10.384797,"eighty":-7.264924,"high":-5.069183,"avg":-10.841843,"sd":3.694257,"marketCap":832563235},"quantilePoints":[{"date":"2024-03-28","current":-7.959158,"twenty":-7.219077,"median":-6.108955,"eighty":-6.016992,"marketCap":556886354},{"date":"2024-04-05","current":-7.492045,"twenty":-7.873034,"median":-7.667213,"eighty":-6.662191,"marketCap":524203432},{"date":"2024-04-12","current":-7.929963,"twenty":-7.855517,"median":-7.667213,"eighty":-7.432197,"marketCap":554843672},{"date":"2024-04-19","current":-6.382653,"twenty":-7.855517,"median":-7.488396,"eighty":-6.783348,"marketCap":446581492},{"date":"2024-04-26","current":-5.638193,"twenty":-7.716113,"median":-7.451903,"eighty":-5.889996,"marketCap":394493084},{"date":"2024-05-03","current":-5.988527,"twenty":-7.671592,"median":-6.864363,"eighty":-5.803142,"marketCap":419005276},{"date":"2024-05-10","current":-5.317808,"twenty":-7.667213,"median":-6.108955,"eighty":-5.803142,"marketCap":393230653},{"date":"2024-05-17","current":-5.708011,"twenty":-7.597146,"median":-6.0013,"eighty":-5.749862,"marketCap":422084590},{"date":"2024-05-24","current":-5.428308,"twenty":-7.489126,"median":-6.006774,"eighty":-5.719496,"marketCap":401401679},{"date":"2024-05-31","current":-5.355793,"twenty":-7.479638,"median":-5.988527,"eighty":-5.522773,"marketCap":396039443},{"date":"2024-06-07","current":-5.193496,"twenty":-7.457742,"median":-5.904593,"eighty":-5.428999,"marketCap":384038248},{"date":"2024-06-14","current":-6.433167,"twenty":-7.451903,"median":-5.930138,"eighty":-5.428308,"marketCap":475706952},{"date":"2024-06-21","current":-6.236339,"twenty":-7.425628,"median":-5.992177,"eighty":-5.43107,"marketCap":461152311},{"date":"2024-06-28","current":-6.150011,"twenty":-7.389135,"median":-6.0013,"eighty":-5.439358,"marketCap":454768696},{"date":"2024-07-05","current":-6.098214,"twenty":-7.269437,"median":-6.014073,"eighty":-5.469746,"marketCap":450938528},{"date":"2024-07-12","current":-6.771573,"twenty":-6.771573,"median":-6.098214,"eighty":-5.493918,"marketCap":500730721},{"date":"2024-07-15","current":-7.261916,"twenty":-7.163847,"median":-6.103393,"eighty":-5.509112,"marketCap":536989651},{"date":"2024-08-02","current":-8.498134,"twenty":-7.266429,"median":-6.108573,"eighty":-5.524305,"marketCap":628403011},{"date":"2024-08-09","current":-8.328931,"twenty":-7.474529,"median":-6.146558,"eighty":-5.597209,"marketCap":615891126},{"date":"2024-08-16","current":-8.944708,"twenty":-7.671592,"median":-6.236339,"eighty":-5.641258,"marketCap":621424629},{"date":"2024-08-23","current":-8.79431,"twenty":-7.94748,"median":-6.352018,"eighty":-5.670717,"marketCap":610975896},{"date":"2024-08-30","current":-8.746816,"twenty":-8.006409,"median":-6.382653,"eighty":-5.719496,"marketCap":607676296},{"date":"2024-09-06","current":-9.451311,"twenty":-8.199004,"median":-6.419354,"eighty":-5.743293,"marketCap":656620360},{"date":"2024-09-13","current":-8.17293,"twenty":-8.352945,"median":-6.434893,"eighty":-5.773217,"marketCap":567806132},{"date":"2024-09-20","current":-8.7389,"twenty":-8.507104,"median":-6.459289,"eighty":-5.788545,"marketCap":607126363},{"date":"2024-09-27","current":-8.806184,"twenty":-8.638371,"median":-6.616182,"eighty":-5.792924,"marketCap":611800796},{"date":"2024-10-04","current":-8.897214,"twenty":-8.745233,"median":-7.269437,"eighty":-5.800953,"marketCap":618125029},{"date":"2024-10-11","current":-9.340491,"twenty":-8.850511,"median":-7.455552,"eighty":-5.81701,"marketCap":648921294},{"date":"2024-10-18","current":-10.417023,"twenty":-8.905129,"median":-7.492045,"eighty":-5.857882,"marketCap":723712222},{"date":"2024-10-25","current":-9.902504,"twenty":-9.0017,"median":-7.670862,"eighty":-5.904593,"marketCap":687966558},{"date":"2024-10-31","current":-10.939457,"twenty":-9.257377,"median":-7.718702,"eighty":-5.904593,"marketCap":760007820},{"date":"2024-11-08","current":-14.709443,"twenty":-9.419648,"median":-7.959158,"eighty":-5.955683,"marketCap":894466512},{"date":"2024-11-15","current":-15.344855,"twenty":-9.514636,"median":-8.00261,"eighty":-5.970448,"marketCap":933105265},{"date":"2024-11-22","current":-15.521232,"twenty":-9.76398,"median":-8.132103,"eighty":-5.988527,"marketCap":943830613},{"date":"2024-11-29","current":-16.100113,"twenty":-9.924668,"median":-8.17293,"eighty":-5.994366,"marketCap":979031755},{"date":"2024-12-06","current":-16.33076,"twenty":-10.388526,"median":-8.285117,"eighty":-6.004584,"marketCap":993057210},{"date":"2024-12-13","current":-13.920266,"twenty":-10.815972,"median":-8.351032,"eighty":-6.018452,"marketCap":846477455},{"date":"2024-12-20","current":-13.694141,"twenty":-11.182468,"median":-8.50374,"eighty":-6.082845,"marketCap":832727009},{"date":"2024-12-27","current":-14.476534,"twenty":-12.093039,"median":-8.531114,"eighty":-6.098214,"marketCap":880303552},{"date":"2025-01-03","current":-12.794163,"twenty":-13.449021,"median":-8.618187,"eighty":-6.102358,"marketCap":778000234},{"date":"2025-01-10","current":-11.912274,"twenty":-13.190334,"median":-8.707238,"eighty":-6.108649,"marketCap":724373495},{"date":"2025-01-17","current":-10.130408,"twenty":-13.019383,"median":-8.746816,"eighty":-6.115785,"marketCap":616019980},{"date":"2025-01-24","current":-11.197719,"twenty":-12.871045,"median":-8.79431,"eighty":-6.143105,"marketCap":680922085},{"date":"2025-01-31","current":-11.523339,"twenty":-12.794163,"median":-8.877425,"eighty":-6.150011,"marketCap":700722728},{"date":"2025-02-07","current":-12.070562,"twenty":-12.328345,"median":-8.905129,"eighty":-6.232886,"marketCap":733998807},{"date":"2025-02-14","current":-11.432889,"twenty":-12.292165,"median":-8.964497,"eighty":-6.236339,"marketCap":695222549},{"date":"2025-02-21","current":-11.279124,"twenty":-12.151063,"median":-8.998138,"eighty":-6.308164,"marketCap":685872246},{"date":"2025-02-28","current":-9.62841,"twenty":-12.079607,"median":-9.059485,"eighty":-6.342695,"marketCap":585493990},{"date":"2025-03-07","current":-10.297741,"twenty":-11.943932,"median":-9.320702,"eighty":-6.355126,"marketCap":626195310},{"date":"2025-03-14","current":-11.193196,"twenty":-11.879712,"median":-9.419648,"eighty":-6.365485,"marketCap":680647077},{"date":"2025-03-21","current":-14.554795,"twenty":-11.943932,"median":-9.482973,"eighty":-6.379634,"marketCap":724377586},{"date":"2025-03-28","current":-14.68208,"twenty":-12.421509,"median":-9.574004,"eighty":-6.398202,"marketCap":730712447},{"date":"2025-04-04","current":-12.728528,"twenty":-13.089934,"median":-9.668992,"eighty":-6.415901,"marketCap":633486102},{"date":"2025-04-11","current":-10.2603,"twenty":-12.90813,"median":-9.741473,"eighty":-6.42488,"marketCap":510644883},{"date":"2025-04-17","current":-12.761733,"twenty":-12.945214,"median":-9.779811,"eighty":-6.430405,"marketCap":635138674},{"date":"2025-04-25","current":-15.833323,"twenty":-13.271407,"median":-9.84549,"eighty":-6.435239,"marketCap":788008663},{"date":"2025-05-02","current":-15.982746,"twenty":-13.932929,"median":-9.940463,"eighty":-6.440764,"marketCap":795445305},{"date":"2025-05-09","current":-15.25222,"twenty":-14.136351,"median":-10.102399,"eighty":-6.452984,"marketCap":728141003},{"date":"2025-05-16","current":-16.118891,"twenty":-14.245886,"median":-10.138549,"eighty":-6.460191,"marketCap":769515850},{"date":"2025-05-23","current":-16.637714,"twenty":-14.356129,"median":-10.19625,"eighty":-6.460792,"marketCap":794284465},{"date":"2025-05-30","current":-17.410053,"twenty":-14.523491,"median":-10.236057,"eighty":-6.585104,"marketCap":831155927},{"date":"2025-06-06","current":-17.864023,"twenty":-14.65894,"median":-10.342966,"eighty":-6.96771,"marketCap":852828466},{"date":"2025-06-13","current":-17.439532,"twenty":-14.747436,"median":-10.384797,"eighty":-7.264924,"marketCap":832563235}],"updateTime":1750066766934}}}